Zoetis Inc. (BVMF:Z1TS34)

Market Cap	293.09B -34.3%
Revenue (ttm)	50.08B +2.7%
Net Income	14.13B +9.1%
EPS	31.64 +11.6%
Shares Out	n/a
PE Ratio	20.75
Forward PE	19.39
Dividend	0.47 (1.13%)
Ex-Dividend Date	Jan 19, 2026

Volume	1,100
Average Volume	309
Open	41.90
Previous Close	41.81
Day's Range	41.57 - 41.90
52-Week Range	39.00 - 64.38
Beta	0.97
RSI	50.76
Earnings Date	Feb 13, 2026

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1950
• Employees: 13,800
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: Z1TS34

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD